ImageneBio, Inc.
IMA· Nasdaq
Released Nov 9, 2026, after the close
10-Q filed Nov 9, 2026, 40 days after period end · 0001193125-26-453624
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | — | $0.00 | $3.50M | $1.19M |
| Net Income | -$15.62M | -$24.78M | -$3.18M | -$17.34M |
| EPS Diluted |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$0.91 |
| -$2.91 |
| -$2.58 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.